Home / Stocks / Solara Active Pha Sci Ltd
SOLARA

Solara Active Pha Sci Ltd Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 25 Sep 2026

₹739.15

Change

+11.8 (1.62%)

Open

₹734.55

Prev. Close

₹727.35

Day High

₹757.9

Day Low

₹732.0

Volume Analysis

Traded

287,888

Delivered

82,713

Delivery %

28.73%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (1)

  • •Promoter holding is rising

Weaknesses (2)

  • •Low return on equity (-0.13%)
  • •Below-average fundamentals quality score (49/100)

Opportunities (0)

No signal for this stock

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹779.94 ₹768.92 ₹754.04 ₹743.02 ₹728.14 ₹717.12 ₹702.24
Fibonacci ₹768.92 ₹759.03 ₹752.91 ₹743.02 ₹733.13 ₹727.01 ₹717.12
Camarilla ₹746.27 ₹743.9 ₹741.52 ₹743.02 ₹736.78 ₹734.4 ₹732.03

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

+31.26%

1 Week

-1.87%

1 Month

+18.51%

3 Months

+28.39%

6 Months

+61.0%

1 Year

+20.13%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

DuPont ROE Breakdown

-0.15%

Net margin -0.14% × asset turnover 0.59x × equity multiplier 1.86x

Company Overview

Sector

Healthcare

Market Cap

₹3,587 Cr

P/E (TTM)

840.0

ROE

-0.13%

Book Value

₹346.0

Face Value

₹10.0

Source: Screener.in (Consolidated figures) — data as of 27 Sep 2026. Not investment advice.

TopFund Analysis

Solara Active Pha Sci Ltd scores weakly on TopFund's composite fundamentals check within the Healthcare sector, at 49/100. The strongest factor is Momentum (90/100), while Growth (0/100) is the weakest area to weigh before deciding. Notably: Promoter holding is rising; low return on equity (-0.13%); below-average fundamentals quality score (49/100). FII holding has been falling.

TopFund Score — Fundamentals Quality

49/100 — Weak

Data confidence: 75/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 27 Sep 2026 · How we calculate this →

Financial Strength

85

Growth

0

Valuation

33

Cash Flow

49

Corporate Governance

66

Momentum

90

Institutional Ownership

42

Business Quality

34

Risk & Volatility

65

Liquidity

58

From Screener.in

  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -3.27% over past five years.
  • −Company has a low return on equity of -12.0% over last 3 years.
  • −Promoters have pledged 37.1% of their holding.

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Company reminded physical shareholders to submit PAN, KYC, bank details and nomination forms.

Income tax rectification order drops Rs.161.92 crore demand for AY 2019-20 to nil.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Sales + 352 425 212 299 363 347 300 273 319 314 349 387 382
Expenses + 333 388 374 290 322 286 243 228 262 279 312 330 320
Operating Profit 19 38 -162 10 42 61 58 45 57 35 37 58 62
OPM % 5.0% 9.0% -76.0% 3.3% 12.0% 18.0% 19.0% 17.0% 18.0% 11.0% 11.0% 15.0% 16.0%
Other Income + 2 -4 -62 -120 1 0 1 6 1 0 -7 6 3
Interest 25 24 25 31 31 28 27 29 24 21 22 28 22
Depreciation 26 26 26 25 25 25 25 24 24 24 26 26 27
Profit before tax -29 -17 -275 -167 -13 8 8 -2 11 -10 -17 10 16
Tax % -35.0% 0.0% 0.0% 53.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Net Profit + -19 -17 -275 -255 -13 8 8 -2 11 -10 -17 10 16
EPS in Rs -4 -4 -57 -53 -4 2 2 -1 3 -3 -5 3 3
Raw PDF — — — — — — — — — — — — —

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 521 1,387 1,322 1,617 1,268 1,444 1,289 1,284 1,369 1,431
Expenses + 464 1,174 1,062 1,231 1,188 1,309 1,384 1,077 1,182 1,240
Operating Profit 57 213 260 386 81 134 -95 206 187 192
OPM % 11.0% 15.0% 20.0% 24.0% 6.0% 9.0% -7.0% 16.0% 14.0% 13.0%
Other Income + 2 12 27 29 16 22 -185 8 0 2
Interest 25 82 78 84 75 90 105 115 95 92
Depreciation 34 83 94 109 112 111 103 99 100 103
Profit before tax 0 60 115 222 -91 -45 -488 1 -7 -2
Tax % -70.0% 1.0% 0.0% 0.0% -36.0% -50.0% 16.0% 0.0% 0.0% —
Net Profit + 0 59 115 221 -58 -22 -567 1 -7 -2
EPS in Rs — 17 32 46 -12 -5 -118 0 -2 -2
Dividend Payout % 0.0% 22.0% 5.0% 11.0% 0.0% -49.0% 0.0% 0.0% 0.0% —

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Reserves 739 930 1,059 1,553 1,489 1,464 898 1,054 1,208
Borrowings + 633 538 722 621 1,037 1,013 1,012 796 687
Other Liabilities + 425 466 346 404 383 386 406 342 393
Total Liabilities 1,821 1,960 2,153 2,614 2,945 2,899 2,351 2,232 2,333
Fixed Assets + 1,086 1,218 1,397 1,382 1,356 1,364 1,268 1,193 1,238
CWIP 71 40 40 88 239 238 256 280 205
Investments 1 0 0 0 0 2 2 2 5
Other Assets + 663 701 716 1,144 1,350 1,295 825 757 886
Total Assets 1,821 1,960 2,153 2,614 2,945 2,899 2,351 2,232 2,333
Equity Capital 25 26 27 36 36 36 36 40 45

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 49 166 242 155 -242 156 109 213 153
Cash from Investing Activity + -85 -113 -359 -106 -243 -81 -4 -37 -99
Cash from Financing Activity + 68 -23 97 92 334 -113 -106 -180 -54
Net Cash Flow 31 30 -20 142 -151 -38 0 -4 1
CFO/OP 92 85 103 49 -277 106 -113 104 83
Free Cash Flow 14 108 -25 -16 -451 46 69 173 101

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 37.19% → 41.93%
  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Public 43.16% 51.14% 50.73% 45.89% 45.11% 44.92% 44.82% 41.1% 41.71% 42.37% 42.66% 42.79%
Promoters 37.19% 30.49% 30.49% 37.27% 37.27% 37.23% 37.94% 42.01% 42.01% 42.0% 42.0% 41.93%
FII 17.86% 16.62% 15.8% 14.0% 14.25% 14.67% 14.63% 14.25% 13.58% 11.98% 11.59% 11.52%
DII 1.79% 1.75% 2.97% 2.83% 3.37% 3.19% 2.61% 2.62% 2.69% 3.64% 3.75% 3.74%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Solara Active Pha Sci Ltd (this stock) 3,587 840.0 2.14 -0.13%
Ind Swift Laboratories Lt 3,489 53.6 2.52 3.87%
Kwality Pharmaceuticals L 3,824 46.8 11.48 22.6%
Unichem Laboratories Ltd 3,870 31.7 1.42 3.17%
Advanced Enzyme Tech Ltd 3,278 20.8 2.01 10.2%
Aarti Drugs Ltd. 3,991 20.7 2.57 13.4%
Gufic Biosciences Ltd. 4,237 57.7 6.37 10.1%

Which Mutual Funds Hold Solara Active Pha Sci Ltd?

Frequently Asked Questions about Solara Active Pha Sci Ltd

Community Sentiment

What are other investors saying about Solara Active Pha Sci Ltd?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.